Matthew Stanton
Stock Analyst at Jefferies
(0.19)
# 4,264
Out of 4,940 analysts
5
Total ratings
33.33%
Success rate
-38.22%
Average return
Main Sectors:
Stocks Rated by Matthew Stanton
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Downgrades: Hold | $20 → $8 | $8.10 | -1.23% | 2 | Aug 7, 2024 | |
| LAB Standard BioTools | Initiates: Buy | $3.25 | $1.28 | +153.91% | 1 | Apr 4, 2024 | |
| BLFS BioLife Solutions | Initiates: Buy | $22 | $22.44 | -1.96% | 1 | Apr 4, 2024 | |
| AZTA Azenta | Initiates: Hold | $64 | $27.98 | +128.73% | 1 | Apr 4, 2024 |
Cryoport
Aug 7, 2024
Downgrades: Hold
Price Target: $20 → $8
Current: $8.10
Upside: -1.23%
Standard BioTools
Apr 4, 2024
Initiates: Buy
Price Target: $3.25
Current: $1.28
Upside: +153.91%
BioLife Solutions
Apr 4, 2024
Initiates: Buy
Price Target: $22
Current: $22.44
Upside: -1.96%
Azenta
Apr 4, 2024
Initiates: Hold
Price Target: $64
Current: $27.98
Upside: +128.73%